| dc.contributor.author | Mohammed, Osman Ali | |
| dc.contributor.author | Ibrahim, Bakhit Yousif | |
| dc.contributor.author | Ihsan, Mohammed Osman | |
| dc.contributor.author | Elfatih, Mohammed Abdallah | |
| dc.contributor.author | Abdelwahab, Abdien Saeed | |
| dc.date.accessioned | 2019-07-10T08:58:36Z | |
| dc.date.available | 2019-07-10T08:58:36Z | |
| dc.date.issued | 2019-06 | |
| dc.identifier.issn | 2349-0063 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/684 | |
| dc.description | Breast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %). | en_US |
| dc.description.abstract | Breast cancer is the most frequently diagnosed and the leading cause of cancer death in women globally. Over the past few decades its incidence has increased but a fall in mortality has been observed due to improvement in survival which is associated with earlier disease detection. This is a prospective cross-sectional descriptive study based on laboratory data of (136) patients with breast cancer carried out from (2012-2017) in Nuclear Medicine and Cancer Research centre - Shendi University and Nuclear Medicine and Cancer Research Centre - Aljazeera University. The investigations were performed on venous blood sample drawn in EDTA container for complete blood count by using auto haematology analyzer (Mindray BC-3000 plus). Regarding anemia among breast cancer, 61/136 (44.9 %) were anemic, while 75/136 (55.1 %) were non anemic. There is high frequency of cancer related anaemia in breast cancer (44.9 %). | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | World Journal of Biology and Medical Sciences | en_US |
| dc.relation.ispartofseries | Volume 6,;Issue-2, 17-22, April - June, 2019 | |
| dc.subject | Breast cancer | en_US |
| dc.subject | Sudan | en_US |
| dc.subject | Anaemia | en_US |
| dc.subject | cancer | en_US |
| dc.subject | Breast | en_US |
| dc.title | Breast Cancer Related Anaemias | en_US |
| dc.type | Article | en_US |